Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Age- and sex-related heterogeneity in prodromal Parkinson's disease.
Heinzel S, Kasten M, Behnke S, Vollstedt EJ, Klein C, Hagenah J, Pausch C, Heilmann R, Brockmann K, Suenkel U, Yilmaz R, Liepelt-Scarfone I, Walter U, Berg D. Heinzel S, et al. Among authors: pausch c. Mov Disord. 2018 Jul;33(6):1025-1027. doi: 10.1002/mds.27349. Epub 2018 Mar 23. Mov Disord. 2018. PMID: 29570852 No abstract available.
Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.
Berg D, Behnke S, Seppi K, Godau J, Lerche S, Mahlknecht P, Liepelt-Scarfone I, Pausch C, Schneider N, Gaenslen A, Brockmann K, Srulijes K, Huber H, Wurster I, Stockner H, Kiechl S, Willeit J, Gasperi A, Fassbender K, Gasser T, Poewe W. Berg D, et al. Among authors: pausch c. Mov Disord. 2013 Feb;28(2):216-9. doi: 10.1002/mds.25192. Epub 2012 Oct 31. Mov Disord. 2013. PMID: 23115051
Neuropsychological impairment in prodromal Parkinson's disease.
Pausch C, Schomburg R, Wagenpfeil S, Wollenweber FA, Bayer C, Fassbender K, Behnke S. Pausch C, et al. J Neurol Sci. 2016 Dec 15;371:117-120. doi: 10.1016/j.jns.2016.10.007. Epub 2016 Oct 8. J Neurol Sci. 2016. PMID: 27871431 No abstract available.
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).
McLaughlin V, Alsumali A, Liu R, Klok R, Martinez EC, Nourhussein I, Bernotas D, Chevure J, Pausch C, De Oliveira Pena J, Lautsch D, Hoeper MM. McLaughlin V, et al. Among authors: pausch c. Adv Ther. 2024 Jan;41(1):130-151. doi: 10.1007/s12325-023-02684-x. Epub 2023 Oct 18. Adv Ther. 2024. PMID: 37851297 Free PMC article.
Treatment strategies and survival of patients with connective tissue disease and pulmonary arterial hypertension: a COMPERA analysis.
Distler O, Ofner C, Huscher D, Jordan S, Ulrich S, Stähler G, Grünig E, Held M, Ghofrani HA, Claussen M, Lange TJ, Klose H, Rosenkranz S, Vonk-Noordegraaf A, Vizza CD, Delcroix M, Opitz C, Pausch C, Scelsi L, Neurohr C, Olsson KM, Coghlan JG, Halank M, Skowasch D, Behr J, Milger K, Remppis BA, Skride A, Jureviciene E, Gumbiene L, Miliauskas S, Löffler-Ragg J, Wilkens H, Pittrow D, Hoeper MM, Ewert R. Distler O, et al. Among authors: pausch c. Rheumatology (Oxford). 2024 Apr 2;63(4):1139-1146. doi: 10.1093/rheumatology/kead360. Rheumatology (Oxford). 2024. PMID: 37462520 Free PMC article.
38 results